ClinicalTrials.gov term: Renal Insufficiency, Chronic
83 trials changed in the last 30 days: 1 stopped, 45 with notable changes, 37 with minor changes only.
Withdrawn before enrolling
Sun Yat-sen UniversityNot applicable NCT07786571 Registry history of NCT07786571 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 2026 to Nov 2027
Bodyport Inc.Not specified NCT07059962 Registry history of NCT07059962 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Feb 1, 2027 to Feb 1, 2028
Sonavex, Inc.Not applicable NCT06190717 Registry history of NCT06190717 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Sep 2027
Also in this update: Study completion pushed from Dec 2026 to Dec 2027
University Hospital GoettingenPhase 3 NCT05944016 Registry history of NCT05944016 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from May 29, 2026 to Mar 2027
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Nov 2027 to Feb 2028
Calliditas Therapeutics ABPhase 4 NCT06712407 Registry history of NCT06712407 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 1, 2027 to Mar 1, 2030
Also in this update: Study completion pushed from Jul 1, 2029 to Sep 1, 2031
W.L.Gore & AssociatesNot applicable NCT04671771 Registry history of NCT04671771 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 2026 to Oct 1, 2027
Also in this update: Enrollment increased: 120 → 160 participants; Interventions modified
Scitech Produtos Medicos SANot applicable NCT06096142 Registry history of NCT06096142 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 2028 to Dec 2030
Also in this update: Recruitment opened; Study completion pushed from Dec 2029 to Dec 2031
Massachusetts General HospitalEarly Phase 1 NCT07358195 Registry history of NCT07358195 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 30, 2026 to Mar 31, 2027
University of New MexicoNot applicable NCT06451458 Registry history of NCT06451458 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 30, 2028 to Dec 31, 2029
Also in this update: Primary endpoint(s) modified; Enrollment increased: 1000 → 2000 participants
The George InstitutePhase 3 NCT06058585 Registry history of NCT06058585 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Apr 30, 2026 to Dec 30, 2026
Also in this update: Recruitment opened; Study completion pushed from Jul 31, 2026 to Jul 31, 2027
University of Illinois at ChicagoNot applicable NCT07210710 Registry history of NCT07210710 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2027
Medical University of GrazNot applicable NCT05642156 Registry history of NCT05642156 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 2026 to Aug 2027
Also in this update: Study completion pushed from Aug 2026 to Sep 2027
Mayo ClinicEarly Phase 1 NCT04626167 Registry history of NCT04626167 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Jun 2029
Also in this update: Study completion pushed from Sep 2026 to Dec 2029
Boston Medical CenterNot applicable NCT04399941 Registry history of NCT04399941 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from May 10, 2026 to May 10, 2027
Peking University First HospitalNot applicable NCT06563765 Registry history of NCT06563765 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 2030 to Apr 2031
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sNot applicable NCT06660277 Registry history of NCT06660277 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from May 2026 to Nov 30, 2026
Also in this update: Enrollment closed, study ongoing; Study completion pushed from May 2026 to Dec 31, 2026
University of Texas at AustinNot applicable NCT05970341 Registry history of NCT05970341 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Recruitment opened; Trial sites expanded: 45 → 478 locations
AstraZenecaPhase 3 NCT07624305 Registry history of NCT07624305 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Trial sites expanded: 25 → 30 locations; Interventions modified
Akebia TherapeuticsPhase 2 NCT07268638 Registry history of NCT07268638 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Trial status changed: Not Yet Recruiting → Active, Not Recruiting
Novo Nordisk A/SNot specified NCT07781371 Registry history of NCT07781371 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 16 participants (planned 18)
BayerPhase 1 NCT07722585 Registry history of NCT07722585 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 135 participants (planned 120)
Boehringer IngelheimPhase 3 NCT07107945 Registry history of NCT07107945 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 54 → 47 locations; and 1 more change in the last 30 days
Astellas Pharma Global Development, Inc.Phase 3 NCT05970172 Registry history of NCT05970172 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 44 → 40 locations
AstraZenecaPhase 1/2 NCT06749457 Registry history of NCT06749457 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
BayerNot specified NCT07232537 Registry history of NCT07232537 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Oct 1, 2026 to Jul 7, 2026; Final enrollment: 8 participants (planned 60)
University of PennsylvaniaNot applicable NCT06310161 Registry history of NCT06310161 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 30, 2027 to Oct 30, 2027
Also in this update: Study completion pushed from Dec 31, 2029 to Apr 30, 2030
Medtronic VascularNot applicable NCT07115953 Registry history of NCT07115953 on ClinicalTrials.gov (opens the registry)
Sponsor refiled this as recruiting (was completed)
Fresenius Kabi Taiwan Ltd.Not applicable NCT06892249 Registry history of NCT06892249 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 238038 participants (planned 150000)
BayerNot specified NCT06608212 Registry history of NCT06608212 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Apr 30, 2029 to May 31, 2029
BayerNot specified NCT07554469 Registry history of NCT07554469 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 30, 2026 to Oct 31, 2026
BayerNot specified NCT06763146 Registry history of NCT06763146 on ClinicalTrials.gov (opens the registry)
Trial status changed: Enrolling by Invitation → Active, Not Recruiting
University Medical Center GroningenPhase 3 NCT05374291 Registry history of NCT05374291 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Mar 31, 2031 to Dec 2, 2024
University of Texas Southwestern Medical CenterNot specified NCT02791880 Registry history of NCT02791880 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Johns Hopkins UniversityNot applicable NCT05321368 Registry history of NCT05321368 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 2026 to Dec 2026
Also in this update: Trial sites expanded: 5 → 13 locations; Study completion pushed from Jan 2027 to Apr 2027
Ingenia Therapeutics INCPhase 1/2 NCT07231679 Registry history of NCT07231679 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 2026 to Nov 2026
East and North Hertfordshire NHS TrustNot specified NCT07713680 Registry history of NCT07713680 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 2026 to Nov 2026
East and North Hertfordshire NHS TrustNot specified NCT07779200 Registry history of NCT07779200 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Mahidol UniversityNot specified NCT06700876 Registry history of NCT06700876 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jun 2030 to Dec 1, 2025; Final enrollment: 94 participants (planned 240)
University of FloridaNot specified NCT02114138 Registry history of NCT02114138 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Dec 31, 2026 to Aug 15, 2026; Final enrollment: 54 participants (planned 60)
University of PennsylvaniaNot applicable NCT06356168 Registry history of NCT06356168 on ClinicalTrials.gov (opens the registry)
Trial completed
Aristotle University Of ThessalonikiNot applicable NCT07427264 Registry history of NCT07427264 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary and study completion moved earlier from Oct 2027 to Jul 2027; Final enrollment: 1500 participants (planned 10000)
Tulane UniversityNot specified NCT06753045 Registry history of NCT06753045 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 30, 2028 to Jul 31, 2028
University of New MexicoNot specified NCT04185844 Registry history of NCT04185844 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 12 → 18 locations
And 1 more change in the last 30 days
Novartis PharmaceuticalsPhase 3 NCT07498335 Registry history of NCT07498335 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 8 → 18 locations
VA Office of Research and DevelopmentPhase 3 NCT05931276 Registry history of NCT05931276 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 557 → 566 locations
CSL BehringPhase 2/3 NCT05485961 Registry history of NCT05485961 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Nov 5, 2026 to Sep 28, 2026
BayerNot specified NCT05348733 Registry history of NCT05348733 on ClinicalTrials.gov (opens the registry)
Interventions modified
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1 NCT06056102 Registry history of NCT06056102 on ClinicalTrials.gov (opens the registry)
Interventions modified
Chinese University of Hong KongNot applicable NCT06715735 Registry history of NCT06715735 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Guang'anmen Hospital of China Academy of Chinese Medical SciencesPhase 2/3 NCT03418779 Registry history of NCT03418779 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Jordan University of Science and TechnologyNot applicable NCT06622200 Registry history of NCT06622200 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Okan UniversityNot specified NCT06611189 Registry history of NCT06611189 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Assiut UniversityNot specified NCT06592781 Registry history of NCT06592781 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Yuanjun YangNot specified NCT06587997 Registry history of NCT06587997 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Aug 2024); last known: Recruiting
University of ChicagoNot applicable NCT06364358 Registry history of NCT06364358 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Jun 2024); last known: Enrolling by Invitation
University of California, IrvineNot applicable NCT05514184 Registry history of NCT05514184 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting
University of British ColumbiaNot applicable NCT04044963 Registry history of NCT04044963 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-19 | NCT07881627 Nutritional Status in Patients With Chronic Kidney Disease Receiving 7.2% Amino Acids… | PT Otsuka Indonesia new | |
| 2026-10-16 | NCT07877103 Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing… | The First Affiliated Hospital of Guangzhou Medical University new | Phase 4 |
| 2026-10-09 | NCT07867444 Virtual Reality-Guided Imagery in Hemodialysis Patients ( VRGI-HD ) | Islamic University of Najaf new | |
| 2026-10-05 | NCT07858331 Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access | Kristin Clemens new | Phase 4 |
| 2026-10-01 | NCT07851454 Walnuts for Cardiorenal Protection in Adults With Chronic Kidney Disease | Institut Investigacio Sanitaria Pere Virgili new | |
| 2026-09-30 | NCT07850713 Comparison of the Effect of Allopurinol Versus Febuxostat on Serum Uric Acid in Patients… | Nishtar Medical University new | |
| 2026-09-28 | NCT07845214 EFFECTS OF HORTICULTURAL THERAPY ON ACUTE STRESS AND SALIVARY CORTISOL LEVELS IN… | Ataturk University new | |
| 2026-09-24 | NCT07839429 Effect of mHealth Intervention on Oral Health-Related Quality of Life Among Adult… | King Faisal University new | |
| 2026-09-23 | NCT07836881 Effects of Supervised Exercise Training on Erythrocyte Deformability in Hemodialysis… | Asia University new | |
| 2026-09-23 | NCT07836556 Improving Health Literacy on Chronic Kidney Disease Among Diabetics: the Malaysian… | Universiti Sultan Zainal Abidin new |
| Early Phase 1 | 12 | |
| Phase 1 | 38 | |
| Phase 1/2 | 31 | |
| Phase 2 | 66 | |
| Phase 2/3 | 6 | |
| Phase 3 | 72 | |
| Phase 4 | 80 |
Assiut University (24) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (16) · AstraZeneca (14) · VA Office of Research and Development (11) · Sohag University (10) · Universidade Federal Fluminense (10) · National Taiwan University Hospital (9) · Assistance Publique - Hôpitaux de Paris (8) · Bayer (8) · Mansoura University (8)